Exercise program for lung cancer patients before surgery
Effect of a Home-based, Supervised Prehabilitation With Wearable Technology for Patients With Non-small Cell Lung Cancer Before Lung Resection: a Single-arm, Prospective Study
NA · Tongji Hospital · NCT05608759
This study is testing a new exercise program using a wearable device for lung cancer patients before surgery to see if it helps them get fitter and recover better.
Quick facts
| Phase | NA |
|---|---|
| Study type | Interventional |
| Enrollment | 30 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Tongji Hospital (other) |
| Locations | 1 site (Wuhan, Hubei) |
| Trial ID | NCT05608759 on ClinicalTrials.gov |
What this trial studies
This study explores the use of a wearable telemedicine device to monitor vital signs and provide real-time adjustments to exercise prescriptions for patients with non-small cell lung cancer (NSCLC) undergoing surgery. It aims to evaluate the safety and compliance of this device while assessing the effectiveness of preoperative exercise programs on patients' cardiopulmonary fitness, postoperative complications, and quality of life. Patients will engage in a multimodal prehabilitation program at home for at least four weeks prior to their elective surgery.
Who should consider this trial
Good fit: Ideal candidates include patients diagnosed with stage I or II NSCLC who can tolerate surgery and are capable of using a smartphone application.
Not a fit: Patients with major medical or psychiatric disorders that could affect exercise, or those who cannot undergo cardiopulmonary exercise testing, may not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could enhance recovery and improve surgical outcomes for lung cancer patients.
How similar studies have performed: While the specific approach of using wearable technology for prehabilitation in lung cancer patients is novel, similar prehabilitation strategies have shown promise in other surgical populations.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Capacity to give informed consent. 2. Are able to tolerate surgery (i.e., segmentectomy, lobectomy) as indicated by standard clinical pre-op evaluation, including pulmonary function tests and cardiopulmonary exercise testing. 3. Patients who can use a smartphone application. 4. Patients who are diagnosed of stage I or II Non-small-cell lung carcinoma (NSCLC) diagnosis, with or without pre-operative histologic confirmation. 5. Patients who can perform an exercise program for at least 4 weeks from the first visit to the preoperative clinic to elective surgery. Exclusion Criteria: 1. Known contraindication for cardiopulmonary exercise testing. 2. Patients who have a major medical or psychiatric disorder that is expected to affect exercise. 3. Pregnancy or lactating women.
Where this trial is running
Wuhan, Hubei
- Tongji Hospital — Wuhan, Hubei, China (RECRUITING)
Study contacts
- Study coordinator: Ni Zhang, Doctor
- Email: zhangnidoc@163.com
- Phone: +8613006315393
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Prehabilitation, Non Small Cell Lung Cancer, Cardiorespiratory Fitness, Surgery, Cardiorespiratory fitness, Non-small cell lung cancer, Exercise, Wearable technology